BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27089519)

  • 1. Simultaneous determination of pradefovir, PMEA and tenofovir in HBV patient serum using liquid chromatography-tandem mass spectrometry and application to phase 2 clinical trial.
    Xiao Q; Wang D; Yang W; Chen L; Ding Y; Yang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():133-140. PubMed ID: 27089519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Sensitive LC-MS-MS Method for the Determination of Adefovir in Human Serum and Urine: Application to a Clinical Pharmacokinetic Study.
    Zhang Y; Shen L; Zhan Y; Xiao QQ; Yang J
    J Chromatogr Sci; 2016 Apr; 54(4):507-15. PubMed ID: 26657410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel LC-MS/MS method for simultaneous quantification of tenofovir and lamivudine in human plasma and its application to a pharmacokinetic study.
    Matta MK; Burugula L; Pilli NR; Inamadugu JK; J V L N SR
    Biomed Chromatogr; 2012 Oct; 26(10):1202-9. PubMed ID: 22222724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of tenofovir in Beagle dogs after oral dosing of tenofovir dipivoxil fumarate using HPLC-MS/MS analysis].
    Wang BL; Hu JP; Sheng L; Chen H; Li Y
    Yao Xue Xue Bao; 2013 Mar; 48(3):390-4. PubMed ID: 23724653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of adefovir in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study.
    Bi HC; Zhong GP; Zhou S; Chen X; Huang M
    Rapid Commun Mass Spectrom; 2005; 19(20):2911-7. PubMed ID: 16167376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an LC/MS/MS method for the determination of tenofovir in monkey plasma.
    Guo J; Meng F; Li L; Zhong B; Zhao Y
    Biol Pharm Bull; 2011; 34(6):877-82. PubMed ID: 21628887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of adefovir in human plasma and its application to a pharmacokinetic study.
    Xiong Z; Zhang Y; Qin F; Qin T; Yang S; Li F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(23):2111-6. PubMed ID: 20630813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of pradefovir and PMEA in healthy volunteers after oral dosing of pradefovir.
    Lin CC; Xu C; Teng A; Yeh LT; Peterson J
    J Clin Pharmacol; 2005 Nov; 45(11):1250-8. PubMed ID: 16239358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a sensitive LC-MS/MS method for the determination of adefovir in human serum and urine.
    Sun D; Wang H; Wang B; Guo R
    J Pharm Biomed Anal; 2006 Sep; 42(3):372-8. PubMed ID: 16765007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High throughput LC-MS/MS method for simultaneous determination of tenofovir, lamivudine and nevirapine in human plasma.
    Valluru RK; B PB; S KS; V PK; Kilaru NB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():117-26. PubMed ID: 23774246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using liquid chromatography-tandem mass spectrometry.
    Kromdijk W; Pereira SA; Rosing H; Mulder JW; Beijnen JH; Huitema AD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():43-51. PubMed ID: 23411018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and specific liquid chromatographic tandem mass spectrometric determination of tenofovir in human plasma and its fragmentation study.
    Yadav M; Mishra T; Singhal P; Goswami S; Shrivastav PS
    J Chromatogr Sci; 2009 Feb; 47(2):140-8. PubMed ID: 19222922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantification of a non-nucleoside reverse transcriptase inhibitor efavirenz, a nucleoside reverse transcriptase inhibitor emtricitabine and a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry.
    Nirogi R; Bhyrapuneni G; Kandikere V; Mudigonda K; Komarneni P; Aleti R; Mukkanti K
    Biomed Chromatogr; 2009 Apr; 23(4):371-81. PubMed ID: 18937306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects.
    Yadav M; Singhal P; Goswami S; Pande UC; Sanyal M; Shrivastav PS
    J Chromatogr Sci; 2010 Oct; 48(9):704-13. PubMed ID: 20875231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, efficacy, and pharmacokinetics of pradefovir for the treatment of chronic hepatitis B infection.
    Zhang H; Wu M; Zhu X; Li C; Li X; Jin W; Zhang D; Chen H; Liu C; Ding Y; Niu J; Liu J
    Antiviral Res; 2020 Feb; 174():104693. PubMed ID: 31838002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients.
    De Nicolò A; Simiele M; Pensi D; Boglione L; Allegra S; Di Perri G; D'Avolio A
    J Pharm Biomed Anal; 2015 Oct; 114():127-32. PubMed ID: 26037161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards.
    Delahunty T; Bushman L; Robbins B; Fletcher CV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1907-14. PubMed ID: 19493710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and implementation of liquid chromatographic-mass spectrometric (LC-MS) methods for the quantification of tenofovir prodrugs.
    Hummert P; Parsons TL; Ensign LM; Hoang T; Marzinke MA
    J Pharm Biomed Anal; 2018 Apr; 152():248-256. PubMed ID: 29433097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of tenofovir alafenamide and tenofovir in human plasma by LC-MS/MS and its application to pharmacokinetics study in clinic.
    Zhao L; Li Z; Zhou Z; Kang X; Fang B; Ma H; Ge Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1117():148-157. PubMed ID: 31031221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A liquid chromatography tandem mass spectrometry based regulatory compliant method for the determination of tenofovir in human serum.
    Paliwal N; Jain P; Dubey N; Sharma S; Khurana S; Kumar Paliwal S
    Drug Res (Stuttg); 2014 Jun; 64(6):306-12. PubMed ID: 24310362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.